ArticleChemical science2025
Enhancing electroluminescence performance of ultra-deep-blue through-space charge transfer emitters with CIE
Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Rigid and Strong Donor Strategy for Solution-Processed Neat-Film Near-Infrared OLEDs Beyond 900 nm.Angewandte Chemie (International ed. in English) · 2026Article
- Beyond 800 nm: recent progress in high-performance near-infrared thermally activated delayed fluorescence based OLEDs.Chemical science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achieving efficient solution-processed ultra-deep-blue OLEDs remains a challenge. Herein, a methyl-modification strategy is proposed to overcome weak intramolecular charge transfer and the large energy gap between the singlet and triplet states (Δ
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.